429 filings
Page 13 of 22
8-K
8fx j9t6z9t
6 Aug 18
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives
5:27pm
8-K
q8g252amu6pv 0c7fj8
23 Jul 18
ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431
12:37pm
8-K
k7kb kumomb2ye9xeo3
5 Jul 18
Material Modifications to Rights of Security Holders
4:03pm
8-K
krq6gu9
25 Jun 18
Other Events
11:24am
424B3
oq52p1wjmcmgrer39rz
22 Jun 18
Prospectus supplement
4:24pm
S-1MEF
p1ajw os9wx
22 Jun 18
Registration of additional securities for an S-1
4:05pm
8-K
hhu094l
21 Jun 18
Other Events
7:58am
8-K
qcfyx2s idzgohvo
19 Jun 18
ContraVir Pharmaceuticals to Provide Corporate, Business and Clinical Updates
12:00am
424B4
w3vha
15 Jun 18
Prospectus supplement with pricing info
12:26pm
8-K
qxwx wbp0
14 Jun 18
ContraVir Pharmaceuticals Announces the Approval of the IND and Initiation of the Clinical Development Program of CRV431 in the United States
12:00am
EFFECT
60j4hs8cqhj8k ng
14 Jun 18
Notice of effectiveness
12:00am
CORRESP
afooj2 hsv
13 Jun 18
Correspondence with SEC
12:00am
8-K
i7k8z8
13 Jun 18
ContraVir Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
12:00am
8-K
4yu065njn59oo6s8o
6 Jun 18
ContraVir Pharmaceuticals Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
6:01am
FWP
ahdq9azu6j6cx0nmwe
5 Jun 18
Free writing prospectus
4:31pm
8-K
16ir2jz4d30xqkg0xb58
31 May 18
Other Events
8:21am